HFE gene mutations in coronary atherothrombotic disease.
暂无分享,去创建一个
[1] J. McCord. Iron, free radicals, and oxidative injury. , 2004, Seminars in hematology.
[2] R. Hegele,et al. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis , 1999, Nature Genetics.
[3] Trip,et al. Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease , 1998, British journal of haematology.
[4] Gillum Rf. Body iron stores and atherosclerosis. , 1997 .
[5] StefanKiechl,et al. Body Iron Stores and the Risk of Carotid Atherosclerosis , 1997 .
[6] W. Poewe,et al. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. , 1997, Circulation.
[7] J. Keaney,et al. Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[8] J. Keaney,et al. Antioxidants and atherosclerotic heart disease. , 1997, The New England journal of medicine.
[9] R. Baumgartner,et al. Impact of HLA-H mutations on iron stores in healthy elderly men and women. , 1997, Blood cells, molecules & diseases.
[10] Jennifer J. Pointon,et al. Global prevalence of putative haemochromatosis mutations. , 1997, Journal of medical genetics.
[11] D. Meyers. The iron hypothesis—Does iron cause atherosclerosis? , 1996, Clinical cardiology.
[12] M. C. Ellis,et al. A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.
[13] C. Venditti,et al. Mutation analysis in hereditary hemochromatosis. , 1996, Blood cells, molecules & diseases.
[14] A. Reunanen,et al. Body iron stores, dietary iron intake and coronary heart disease mortality , 1995, Journal of internal medicine.
[15] J. Araujo,et al. Iron overload augments the development of atherosclerotic lesions in rabbits. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[16] J. Salonen,et al. Body iron stores and the risk of coronary heart disease. , 1994, The New England journal of medicine.
[17] W. Willett,et al. Are body iron stores related to the risk of coronary heart disease? , 1994, The New England journal of medicine.
[18] H. Morrison,et al. Serum iron and risk of fatal acute myocardial infarction. , 1994, Epidemiology.
[19] M. Burt,et al. Iron and coronary heart disease. , 1993, BMJ.
[20] H. Macdonald. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. , 1993, Circulation.
[21] Heikki Korpela,et al. High Stored Iron Levels Are Associated With Excess Risk of Myocardial Infarction in Eastern Finnish Men , 1992, Circulation.
[22] W. Willett,et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.
[23] J. Manson,et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. , 1991, The New England journal of medicine.
[24] R. Lauffer. Iron stores and the international variation in mortality from coronary artery disease. , 1991, Medical hypotheses.
[25] K. Mullis,et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.
[26] J. Sullivan. IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK , 1981, The Lancet.
[27] F. Skrabal. RECTAL POTENTIAL DIFFERENCE IN ESSENTIAL HYPERTENSION , 1976, The Lancet.
[28] B. Woolf. ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE , 1955, Annals of human genetics.
[29] N. Andrews,et al. Iron is hot: an update on the pathophysiology of hemochromatosis. , 1998, Blood.
[30] T. Bothwell,et al. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. , 1998, Seminars in hematology.
[31] J. George,et al. Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults. , 1998, Seminars in hematology.
[32] C. Hennekens,et al. Iron status and risk of cardiovascular disease. , 1997, Annals of epidemiology.
[33] J. Jessurun,et al. Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. , 1995, The American journal of pathology.